Description
E-45 Body Cream 125g moisturises and relieves dry skin conditions such as eczema. It is excellent as a supportive treatment in burns of varying degrees, particularly where joints are involved and movement is impaired by dryness and cracking.
Pack Size: 125g
Dosage and Directions: Apply as required. For external use only.
Storage instructions: Store below 25 degrees C.
Warnings: Keep out of reach of children. Known symptoms of over dosage and particulars of its treatment: Symptoms: there have been no reports of over dosage with the use of this product. Management: in the unlikely case of over dosage, treatment should be symptomatic and supportive. Contra-indications: Hypersensitivity to white soft paraffin, light liquid paraffin, anhydrous lanolin or to any other ingredients of cream E45 (citric acid monohydrate, sodium hydroxide, sodium cetostearyl sulphate, carbomer). Warnings and special precautions: If rash develops, use of the product should be discontinued. Patients being dispensed or treated with large quantities (>100g) of any paraffin based product should be advised to regularly change clothing, bedding or dressings impregnated with the product and keep away from naked flames as there is a fire hazard. Effects on ability to drive and use machines: the product has no or negligible influence on the ability to drive and use machines. Pregnancy and lactation: pregnancy: no effects during pregnancy are anticipated, since systemic exposure to white soft paraffin, liquid paraffin and lanolin is negligible. As with all medicines, this product should be used with caution during pregnancy. Lactation: it is unknown whether white soft paraffin, light liquid paraffin and anhydrous lanolin metabolites are excreted in human milk. A risk to the newborns/infants cannot be excluded. Application of the product to the breast is not recommended during breast feeding. Fertility: No data on human fertility are available. Side-effects: Adverse events which have been associated with white soft paraffin, light liquid paraffin and anhydrous lanolin are given below, tabulated by system organ class and frequency. Frequencies are defined as: Very common (=1/10); Common (=1/100 and <1/10); Uncommon (=1/1000 and <1/100); Rare (=1/10,000 and <1/1000); Very rare (<1/10.000); not known (cannot be estimated from the available data). Within each frequency grouping, adverse events are.